Alternatives to Everly Bio

AI-powered patient-centric drug simulations to accelerate and de-risk drug development.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

Revolutionizing prenatal testing with non-invasive fetal DNA analysis from maternal blood.

AI platform for discovering complex multi-omics signatures for personalized medicine.

Cloud-based platform for reproducible computational research in life sciences.

OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability.

Drug discovery and development company using a novel technological approach.

Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

Developing microbiome-derived therapies to overcome resistance to immune checkpoint inhibitors in cancer treatment.

Genomic and data science company developing novel drugs based on natural resistance mechanisms.

Develops Array Cytometry technology for large-scale dynamic single-cell response acquisition and predictive modeling.

Leveraging AI and novel technology to extract deep health insights from routine blood tests.

AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.

Develops a platform for adaptive clinical trial design and closed-loop execution.

AI-driven platform for protein-level disease mapping and drug discovery.

Computational platform using LLMs trained on biological and chemical data for drug discovery.

AI-powered blood test for early cancer detection and subtyping.

AI-powered epiproteomic analysis platform for mass spectrometry data.

Developing exosome-based cancer therapeutics using AI and novel human cancer models.

Digital pathology imaging technology and AI-driven precision pathology software.